Press Releases

Elegen Raises $35 Million in Series B to Accelerate Expansion into Clinical Manufacturing

Elegen is leveraging their next-generation DNA synthesis and production technology to expand into clinical DNA scaleup and manufacturing, a move supported by this Series B round with new investors Trianomic Capital, GSK, and Aldevron co-founder John Ballantyne as well as existing investors. This expansion into clinical applications comes just a little over a year after launching their first product, ENFINIA DNA. To date the company has rapidly enhanced its platform to speed the upstream discovery phase of genetic medicine development, and in January announced a collaboration and licensing agreement with GSK. Investors are confident that Elegen's cell-free, turnkey synthetic DNA platform will transform the speed and reliability of clinical GMP DNA manufacturing.

LG UNVEILS ‘PRIMEFOCUS HEALTH,’ NEW VENTURE IN HOME HEALTHCARE TREATMENT

LG Electronics has launched “Primefocus Health,” a new venture that aims to leverage innovative technologies and new healthcare therapies to enable providers to deliver a personalized, complete care experience and empower individuals to take control of their health at home. This new provider-focused, patient-centric healthcare platform intends to give patients access to new healthcare therapies made available by innovative technology applications, as well as providers access to patient data and progress information to help ensure that their patients are on the right path to better health. Primefocus Health is the first new venture launched by LG NOVA, LG Electronics’ North America Innovation Center.

PrecisionLife and Metrodora Institute Launch Clinical Trials to Accelerate the Diagnosis and Treatment of ME/CFS and Long Covid Patients

Metrodora Institute and PrecisionLife announce the start of recruitment on a cohort of up to 1,000 patients into clinical trials to evaluate new diagnosis and treatment options for ME/CFS, Long Covid, and related disorders.

Torbay Pharma strengthens leadership team to support North American growth strategy

Amerigo Scientific Adds Magnetic Silica Beads to Enlarge Its Nucleic Acid Extraction and Purification Toolbox

Cresset Targets Global Growth with New India HQ

Drug discovery specialist Cresset has announced a major milestone in its international growth with the launch of a new Indian HQ in Bangalore.

ECI Unveils Dynamic New Identity With A Fresh Vision for Global Leadership

ECI is thrilled to unveil its strategic rebranding, which combines Enhanced Compliance, Inc. and its Costa Rica-based subsidiary CRx Life Sciences into one entity and signals a critical juncture in the company’s ongoing growth and dedication to innovation in the life sciences industry. This fundamental transformation includes a refreshed brand identity, focusing on a refined brand structure and elevated visual appeal.

Verisense Health Elects Josh Tolkoff to its Board of Directors

Josh brings extensive medical device, investment, and growth management experience to his new role.

Sharp Services announces expansion in Pennsylvania to facilitate growth in sterile injectable market

Dr. Tim Garnett, Former Chief Medical Officer of Eli Lilly, Joins Lindus Health's Advisory Board

Dr. Tim Garnett, Former Chief Medical Officer of Eli Lilly, Joins Lindus Health's Advisory Board

Clinical Study Highlights Improvements to Gut Microbiome and Autism Spectrum Disorder Symptoms with Use of Custom Probiotics

Researchers with Sun Genomics and Arizona State University (ASU) have discovered that probiotic supplementation may improve symptoms in people with autism spectrum disorder. The joint metagenomics study assessed the effects of customized probiotic supplementation on children and adults with autism.

PumasAI Named Best Clinical Pharmacology Technology Development Firm in Biotechnology Awards

Alfa Chemistry Rolls Out Various Nucleic Acid Delivery Options for Nucleotide Vaccine Research

CD Formulation Unveils Hydrogel Microneedle Patch Technology to Increase Drug Loading Capacity

Clinical studies have demonstrated minoxidil's effectiveness, particularly in mild to moderate cases of hair loss

Clinical studies have shown that minoxidil can effectively promote hair regrowth in individuals with alopecia areata, particularly in mild to moderate hair loss cases. Results may vary from person to person, and not everyone may respond to minoxidil treatment. To see the best results, it's also essential to use minoxidil consistently and as directed. This means applying it regularly to the affected areas of the scalp and continuing treatment even after hair regrowth occurs to maintain results.

LogiPharma 2024 Highlights: Record Attendance and Groundbreaking Insights

Around 2,000 people attended the 2024 edition of LogiPharma, the annual leading life sciences and supply chain event, making it the largest to date – with 70 percent of exhibition booths already booked for 2025.

Particle Dynamics Appoints New CFO as it Advances its Strategic Growth Plans

One of the world’s leading oral solid dosage technology companies Particle Dynamics has announced a major new addition to its top team with the appointment of Mike Kanan as Chief Financial Officer

EDETEK to Present Keynote Presentation at 15th Clinical Trials Strategic Summit Presentation will Address Solutions to Real-Time Management of Complex Clinical Data

Munther Baara, VP, Product Strategy & Innovation, EDETEK, Inc. delivered a keynote presentation entitled, “Unlock Clinical Data to Guide Agile Decision Making.” This presentation explores EDETEK's innovative solutions that empower sponsors to seamlessly access, analyze, and act upon clinical data. Mr. Baara’s presentation will highlight the role of the CONFORM™ informatics platform and how this innovative software tool delivers foundational and fundamental solutions in an ever-changing clinical informatics ecosystem.

Quest Diagnostics to Acquire PathAI Diagnostics to Accelerate AI and Digital Pathology Adoption in Cancer Diagnosis; Forms Licensing Agreements with PathAI

Quest Diagnostics, a leader in diagnostic information services, and PathAI, a global provider of AI-powered pathology technology, have joined forces to accelerate digital and AI pathology innovations. This collaboration aims to enhance the quality, speed, and efficiency of diagnosing cancer and other diseases, marking a monumental advancement in medical diagnostics.

Revolutionizing Patient Care: ProPharma and PBL Launch Innovative Cell & Gene Therapy Manufacturing Device

First-of-its-kind Cell Factory Box streamlines production, making advanced treatments accessible and affordable